STRIASCAN

This brand name is authorized in Austria, Estonia, Spain, France, Ireland, Lithuania, Poland, United Kingdom

Active ingredients

The drug STRIASCAN contains one active pharmaceutical ingredient (API):

1 Ioflupane ¹²³I
UNII 3MM99T8R5Q - IOFLUPANE I-123

Ioflupane ¹²³I is a radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emission computed tomography (SPECT) brain imaging to assist in the evaluation of adult patients with suspected Parkinsonian syndromes (PS).

Read about Ioflupane ¹²³I

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
STRIASCAN Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V09AB03 Iodine ioflupane (123I) V Various → V09 Diagnostic radiopharmaceuticals → V09A Central nervous system → V09AB Iodine (123I) compounds
Discover more medicines within V09AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1798690, 1798702
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1191372001
Country: FR Base de données publique des médicaments Identifier(s): 69037684
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 395659
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1088129, 1088130
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100423230

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.